Health Canada Approves First RSV Vaccine for Adults Age 60 and Over

Health Canada Approves First RSV Vaccine for Adults Age 60 and Over
Seniors wait after receiving a first dose of COVID-19 vaccine at a vaccination clinic in Montreal on Mar. 10, 2021. The Canadian Press/Paul Chiasson
The Canadian Press
Updated:
0:00
Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over.

Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and require hospitalization.